🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The UPNAT Node is grateful to the Oligonucleotide Therapeutics Society for their support of our upcoming Symposium on 27 June 2024 in London (registration now open: shorturl.at/ftxIM) More info about Oligonucleotide Therapeutics Society Delivery Grants here: oligotherapeutics.org

An impressive line-up of speakers confirmed for the upcoming UPNAT Symposium! Full details below. Registration is open, 27 June in person at UCL Institute of Child Health eventbrite.co.uk/e/uk-platform-…

Interested in RNA therapies for rare disease? sign up for our upcoming UK Platform for Nucleic Acid Therapies- UPNAT symposium

Agenda confirmed for the UPNAT Symposium, with focus on 1) NAT Target Selection for Rare Disease, and 2) Clinical trials and Regulatory Path. Registration is open shorturl.at/ftxIM 27 June at UCL Great Ormond Street Institute of Child Health #RareDisease #NucleicAcid #ClinicalTrials

🔦 Speaker Spotlight 🔦 Stephan Sanders, Prof of Neurogenetics Department of Paediatrics, will speak next week at the #UPNAT Symposium about academic efforts in target selection for #raredisease Registration for 27 June UCL Great Ormond Street Institute of Child Health ➡️ shorturl.at/ftxIMSession University of Oxford Medical Sciences

🔦 Speaker Spotlight 🔦 Ana Lisa Taylor Tavares, Clinical Lead for #RareDisease #Research at Genomics England, will look at collaborations across the UK Rare Disease research landscape. Spaces available for #UPNAT Symposium on 27 June ➡️register here ➡️ shorturl.at/ftxIMSession

🔦Speaker Spotlight🔦 David Fischer, Chief Technology Officer for Discovery at Charles River Labs Charles River Labs, will provide industry perspective at the upcoming UK Platform for Nucleic Acid Therapies- UPNAT Symposium. Register for our event, this Thursday 27 June at UCL ICH➡️ shorturl.at/ftxIMSession

Registration for tomorrow's Symposium has closed shorturl.at/ftxIMSession For late registration, contact [email protected]. Thanks to the UPNAT Team for putting together what promises to be an exciting event! Dr Haiyan Zhou Alice Davidson Mina Ryten Nick Lench Carlo Rinaldi Rare Disease Research UK

Today we are in London at the Inaugural Symposium of the UK Platform for Nucleic Acid Therapies UK Platform for Nucleic Acid Therapies- UPNAT Rare Disease Research UK which set to be an invaluable resource for the #raredisease community. Introduction by Dr Haiyan Zhou the Director of UPNAT

Really inspiring and thought provoking discussions around the patient, disease and variant selection process for rare disease RNA therapy development UK Platform for Nucleic Acid Therapies- UPNAT

We shared the excitement as Haiyan Zhou Dr Haiyan Zhou presented an update on her research as Harrington Scholar Harrington Discovery Institute. And appreciated the introduction to our UK Platform for Nucleic Acid Therapies- UPNAT! #OxfordHarrington2024 Oxford-Harrington Rare Disease Centre Rare Disease Research UK #RareDisease

Exciting to hear about how UPNAT will support and drive development of nucleic acid therapeutics across the UK under Prof Zhou's leadership! #OxfordHarrington2024 Rare Disease Research UK UCL Great Ormond Street Institute of Child Health Dr Haiyan Zhou

An exciting Research Assistant position in the Zhou Lab on RNA drug development. here is the applicaiton link: ucl.ac.uk/work-at-ucl/se… Application deadline 20th Oct 2024. Please do help circulate it.

📢 Calling all UK neuromuscular researchers and friends of Muscular Dystrophy UK at #WMS2024 – pop along to stand 32 and chat to John about all things research and our grant round shorturl.at/Oqmbh 👥🗣️👩‍🦼💡🧬🔬💊🩺🧪

Huge congratulations to Pambos, Konstantina Konstantina Tetorou and Ivan, our young talents who have won the best presentation Prizes from the World Muscle Society International Congress in Prague! Very proud of you 👏🎉 DN ICH @GGM_ICH

Oxford-Harrington is delighted to welcome Lord Cameron David Cameron as Chair of our Advisory Council, leading our international efforts to drive the Centre’s mission of delivering 40 new therapies for rare diseases into clinical trials over the coming decade.

We are delighted to announce today the inaugural 2024 Oxford-Harrington Rare Disease Scholars, selected from a large number of outstanding proposals from the US, UK and Canada, to develop breakthrough treatments for #rarediseases. Congratulations to the ten Scholars!

I'm excited to share that I have started a new role as a Research Fellow at UCL Great Ormond Street Institute of Child Health where I'll be working in Prof. Dr Haiyan Zhou research group developing cell-targeting peptides for nucleic acid delivery.

5 Partners & 1 Associated partner of #EFFecT are present at SMOT (Synergistic Meeting on Oligonucleotide Therapeutics) celebrating #rarediseaseday. We are looking forward to start working together! Remember we are recruiting until March 15!!!📢 euraxess.ec.europa.eu/jobs/296420

The 13th London Myology Forum is taking place on the Wednesday 4th June 2025 at the Elvin Hall, UCL IOE, 20 Bedford Way, WC1H 0AL. Free event, registration required by contacting Jane at [email protected]